A Clinical Evaluation of Monoclonal CA199 CA50 CA 125 and Polyclonal CEA TPA AntibodyDefined Antigens for the Diagnosis of Pancreatic Cancer

MLA

Benini, L., et al. “A Clinical Evaluation of Monoclonal CA199 CA50 CA 125 and Polyclonal CEA TPA AntibodyDefined Antigens for the Diagnosis of Pancreatic Cancer.” Pancreas, vol. 3, no. 1, Feb. 1988, pp. 61–66. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs48923837&authtype=sso&custid=ns315887.

APA

Benini, L., Cavallini, G., Zordan, D., Rizzotti, P., Rigo, L., Brocco, G., Perobelli, L., Zanchetta, M., Pederzoli, P., & Scuro, L. A. (1988). A Clinical Evaluation of Monoclonal CA199 CA50 CA 125 and Polyclonal CEA TPA AntibodyDefined Antigens for the Diagnosis of Pancreatic Cancer. Pancreas, 3(1), 61–66.

Chicago

Benini, L., G. Cavallini, D. Zordan, P. Rizzotti, L. Rigo, G. Brocco, L. Perobelli, M. Zanchetta, P. Pederzoli, and L. A. Scuro. 1988. “A Clinical Evaluation of Monoclonal CA199 CA50 CA 125 and Polyclonal CEA TPA AntibodyDefined Antigens for the Diagnosis of Pancreatic Cancer.” Pancreas 3 (1): 61–66. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs48923837&authtype=sso&custid=ns315887.